Sequenom's HerediT Universal

Sequenom Laboratories, a wholly owned subsidiary of Sequenom, has launched the HerediT Universal carrier screening test, expanding the firm's reach into the universal carrier screening market. The HerediT Universal test screens for more than 250 genetic diseases by analyzing over 2,000 genetic mutations and can be performed preconception or at any time during pregnancy, the firm said. The test is being offered in collaboration with Recombine, a clinical genetic testing firm.


Promega PowerQuant System

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.